Goradia Innovation Prize
The Goradia Innovation Prize is awarded to those early stage companies that have commercialized or are very close to commercializing innovative technologies within the region. The selection of awardees is based upon the commercial potential of the innovation, the soundness of the business plan, the potential for job growth within the region and the likelihood of significant long-term success. The prize is a direct grant to be applied to bringing the technology to market.
A structured and disciplined process will be used by a prestigious panel of judges to evaluate the finalists and select the prize winners.
For 2012, the Goradia Innovation Prize will provide $150,000 in prize money to the Houston Technology Center to fund the prizes. The prizes will be generally distributed as follows:
• $50,000 Grand Innovation Award
The Houston Technology Center gratefully acknowledges the support and contribution of Vijay Goradia and Dr. Marie Goradia and their family for establishing the prestigious Goradia Innovation Prize and their $1 million donation to the fund which will be distributed over 10 years. HTC additionally acknowledges the Greater Houston Partnership’s Opportunity Houston marketing program for their donation of $100,000 to the 2011 and 2012 Goradia Innovation Prize.
Winners of the Goradia Innovation Prize will be announced at the Innovation Conference & Showcase presented by the Houston Technology Center on October 3, 2012, at the Hyatt Regency Houston.
2011 Winners:
Grand Prize Winner ($50,000) OsComp Systems Inc. extends the economical production of liquids-rich shale wells through the application of its proprietary high efficiency multiphase compressor.
First Prize Winner ($35,000) Signal Advance, Inc. has developed proprietary Signal Advance Technology (SAT) that temporally advances signal detection offsetting transmission/response delays leading to improved system performance.
Second Prize Winner ($25,000) Shape Memory Therapeutics, Inc. is commercializing breakthrough neurovascular device to treat cerebral aneurysm with features well ahead of competition in a rapidly growing $1B market.
Third Prize Winner ($15,000) Noninvasix, Inc. is commercializing a novel, noninvasive blood diagnostic platform to replace invasive blood sampling and catheterization for millions each year.
Honorable Mentions ($5,000 each):
Arcos, Inc.’s clinical decision support software improves outcomes for critical care and has enabled The Methodist Hospital System® to reduce sepsis mortality from 34% to 14%. Canopy Edge, Inc. is developing a first-of-its-kind device platform for therapy delivery using a patented Percutaneous Close Loop Perfusion System with first target use for anticancer agents to target organs. Nano3D Biosciences, Inc. has a breakthrough technology for growing cells that is faster, easier and produces greater yield than any other existing 3D cell culturing method today. Osteocene is developing a revolutionary bone reconstruction technology that repairs form, restores function, and manages infections.
• Commercial Potential – is the company likely to succeed and what levels of financial results can be anticipated?
2012 Application Submission Open
Deadline for Applications, Noon, July 9, 2012